LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | WZ-4-145 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 2178 | 4093 | 0.5321 | 0.3359 |
MCF7 | XMD16-144 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 1495 | 4093 | 0.3653 | 0.0991 |
MCF7 | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 3943 | 4093 | 0.9634 | 0.9480 |
MCF7 | Buparlisib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 1418 | 4093 | 0.3465 | 0.0724 |
MCF7 | BX-912 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 2683 | 4093 | 0.6557 | 0.5112 |
MCF7 | Canertinib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 3428 | 4093 | 0.8377 | 0.7696 |
MCF7 | Celastrol | 0.37 | uM | LJP6 | 72 | hr | 1209 | 2695 | 4093 | 0.6586 | 0.5154 |
MCF7 | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 566 | 4093 | 0.1384 | -0.2231 |
MCF7 | CGP60474 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 782 | 4093 | 0.1912 | -0.1481 |
MCF7 | CHIR-99021 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 3606 | 4093 | 0.8812 | 0.8313 |
MCF7 | CP724714 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 3529 | 4093 | 0.8622 | 0.8044 |
MCF7 | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 4156 | 4093 | 1.0156 | 1.0221 |
MCF7 | Crizotinib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 3073 | 4093 | 0.7509 | 0.6464 |
MCF7 | Momelotinib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 3620 | 4093 | 0.8844 | 0.8360 |
MCF7 | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 1636 | 4093 | 0.3997 | 0.1479 |
MCF7 | Dasatinib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 1671 | 4093 | 0.4084 | 0.1603 |
MCF7 | Dovitinib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 2707 | 4093 | 0.6615 | 0.5194 |
MCF7 | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 1209 | 4092 | 4093 | 0.9999 | 0.9999 |
MCF7 | Erlotinib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 4208 | 4093 | 1.0282 | 1.0400 |
MCF7 | Foretinib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 1490 | 4093 | 0.3641 | 0.0974 |
MCF7 | R406 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 4158 | 4093 | 1.0160 | 1.0227 |
MCF7 | Pictilisib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 1212 | 4093 | 0.2963 | 0.0011 |
MCF7 | Gefitinib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 3898 | 4093 | 0.9525 | 0.9326 |
MCF7 | Geldanamycin | 0.37 | uM | LJP5 | 72 | hr | 1209 | 1285 | 4093 | 0.3140 | 0.0263 |
MCF7 | Geldanamycin | 0.37 | uM | LJP6 | 72 | hr | 1209 | 1273 | 4093 | 0.3112 | 0.0222 |